Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer


GAITHERSBURG, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Greg Weaver as Chief Financial Officer (CFO), effective immediately. Mr. Weaver will lead the Company’s finance and accounting functions, including SEC reporting and investor relations.

Follow this link:
Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer

Related Posts